| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Waqoo Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,222.00 |
| 52 Week High | JP¥2,770.00 |
| 52 Week Low | JP¥1,171.00 |
| Beta | 0.82 |
| 11 Month Change | -33.73% |
| 3 Month Change | -33.15% |
| 1 Year Change | -46.73% |
| 33 Year Change | -26.61% |
| 5 Year Change | n/a |
| Change since IPO | -43.69% |
Recent News & Updates
Shareholder Returns
| 4937 | JP Personal Products | JP Market | |
|---|---|---|---|
| 7D | -30.9% | -5.7% | -11.1% |
| 1Y | -46.7% | -11.0% | 4.7% |
Return vs Industry: 4937 underperformed the JP Personal Products industry which returned -15% over the past year.
Return vs Market: 4937 underperformed the JP Market which returned -3.7% over the past year.
Price Volatility
| 4937 volatility | |
|---|---|
| 4937 Average Weekly Movement | 8.1% |
| Personal Products Industry Average Movement | 5.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in JP Market | 9.7% |
| 10% least volatile stocks in JP Market | 3.2% |
Stable Share Price: 4937's share price has been volatile over the past 3 months.
Volatility Over Time: 4937's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 50 | Bunpei Samata | waqoo.jp |
Waqoo Inc. plans, develops, and sells cosmetics in Japan. It offers skin care products, such as moist gel, cleansing, facial cleanser, hot cleansing, whitening serum, whitening face wash, serum, and whitening cleansing products; proteins; makeup base; and hair care products, including shampoo, hair oil and mask, and head spa hair growth agent products under the HADA NATURE brand through its own e-commerce site. The company also provides medical support services comprising advertising services; and regenerative medicine related services, such as blood-derived processing and fat-derived stem cell processing contract services.
Waqoo Inc. Fundamentals Summary
| 4937 fundamental statistics | |
|---|---|
| Market cap | JP¥4.42b |
| Earnings (TTM) | -JP¥293.00m |
| Revenue (TTM) | JP¥1.76b |
2.5x
P/S Ratio-15.1x
P/E RatioIs 4937 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4937 income statement (TTM) | |
|---|---|
| Revenue | JP¥1.76b |
| Cost of Revenue | JP¥446.00m |
| Gross Profit | JP¥1.31b |
| Other Expenses | JP¥1.61b |
| Earnings | -JP¥293.00m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 13, 2024
| Earnings per share (EPS) | -80.96 |
| Gross Margin | 74.66% |
| Net Profit Margin | -16.65% |
| Debt/Equity Ratio | 39.1% |
How did 4937 perform over the long term?
See historical performance and comparison